India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...

From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

India’s pharmaceutical exports reached US$ 30.47 billion in FY 2024–25, and the sector remains optimistic about further growth, driven by strong global demand and resilient production capabilities.

Entering 2026, India's pharmaceutical industry initiates a crucial five-year plan to evolve into an innovation hub, aiming for a USD 500 billion valuation by 2047.

Regeneron Pharmaceuticals (NASDAQ: REGN) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...

Sun Pharma's Managing Director, Kirti Ganorkar, predicts that new age medicines for obesity and diabetes will drive the ...

Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...

India’s pharmaceutical exports reached $30.47 billion in FY 2024–25, registering a 9.4 per cent year-on-year growth, and are ...

India’s pharmaceutical sector is heading into a split-screen 2026, with brokerage commentary pointing to a year marked by ...

The Ministry of Public Health (MoPH) affirmed its commitment to supporting the national pharmaceutical industry in a way that meets local needs and meets th ...